You are here

Global Health

Primary tabs

The mission of the Global Health Working Group is to explore and improve current and emerging states of health and human security worldwide.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 
Group description: 
This Working Group is focused on exploring current and emerging states of health and human security worldwide.
Group roles and permissions: 
Use default roles and permissions
Group visibility: 
Public - accessible to all site users

Members

Aboubacar Conte admin Albert Gomez Allan Anthony Carrielaj
Chisina Kapungu ChrisAllen Corey Watts CPetry DeannaPolk Elhadj Drame
Gavin Macgregor... Hadiatou Balde hank_test jranck JSole Kathy Gilbeaux
Lisa Stelly Thomas loguest Maeryn Obley mdmcdonald MDMcDonald_me_com Mika Shimizu
mike kraft njchapman Norea Tiaji Salaam-Blyther tnovotny

Email address for group

Vaccine shortages hit poor countries, affecting at least 60 nations

LONDON (AP) — As many as 60 countries, including some of the world’s poorest, might be stalled at the first shots of their coronavirus vaccinations because nearly all deliveries through the global program intended to help them are blocked until as late as June.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Scientists are trying to find a simple pill to treat Covid-19 ...but

The world has vaccines that can prevent most cases of Covid-19. It even has drugs that can help with the most serious symptoms of the disease. Now what it needs is a Tamiflu for SARS-CoV-2.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Rise of Variants in Europe adds to coronavius dangers

Europe, the epicenter of the coronavirus pandemic last spring, has once again swelled with new cases, which are inundating some local hospitals and driving a worrisome global surge of Covid-19.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Moderna’s COVID-19 vaccine provides antibodies for at least 6 months after the second dose but fades for older persons

Antibodies persisted 6 months after the second dose of Moderna's COVID-19 vaccine in younger and middle-age adults, but were diminished in older adults when using more sensitive assays, according to data from an ongoing phase I trial.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 1.333 seconds.